This study was designed to investigate adiponectin levels and their relationship to various parameters at baseline and after 5 years in non-obese first-degree relatives of type 2 diabetes patients (FDR group) versus subjects without a family history of diabetes (normal group). Adiponectin levels at baseline were lower in the FDR group versus the normal group. After 5 years, adiponectin levels had fallen significantly in both the FDR (24.3% reduction) and the normal (35.7% reduction) groups. Adiponectin levels were negatively correlated with waist/hip ratio, fasting plasma glucose, carotid intima-media thickness (IMT) and insulin resistance in the FDR group. When adjusted for relevant risk factors, adiponectin was associated with age, high-density lipoproteincholesterol and IMT; these factors explained 45% of the variation in adiponectin in the FDR group. In the normal group, multiple regression analyses revealed that lowdensity lipoprotein-cholesterol and IMT explained 25% of the variability in the adiponectin concentration. In both groups, however, the correlation between adiponectin and IMT just failed to reach statistical significance in this population group. We conclude that adiponectin levels were reduced in non-obese first-degree relatives of patients with type 2 diabetes and normal individuals over a 5-year period. This study supports previous findings that hypoadiponectinaemia is a risk factor for atherosclerosis.
Introduction
Adiponectin, a 30 kDa protein, is synthesized exclusively by adipose tissue 1 and has been reported to have anti-inflammatory, antidiabetic and antiatherogenic properties. Decreased serum concentrations of adiponectin have been described in association with obesity, 2,3 insulin resistance, 4 metabolic syndrome, 2 type 2 diabetes, 2,5 essential hypertension, 6 coronary artery disease, 7 dyslipidaemia 8 and in firstdegree relatives of type 2 diabetes patients. 9 Low baseline adiponectin concentrations have been shown to predict the future J Liu, F Wang, Y Cha et al. Adiponectin levels in type 2 diabetes development of impaired glucose regulation and type 2 diabetes mellitus, whereas elevated baseline levels have been shown to be protective against the subsequent development of type 2 diabetes. 5, 10 First-degree relatives of individuals with type 2 diabetes are at increased risk of developing glucose intolerance and diabetes. Several studies have been published concerning circulating adiponectin concentrations in first-degree relatives, 9,11 -13 but the results have been inconsistent. Among these studies, Osei et al. 11 reported that low adiponectin levels were an important determinant of glucose tolerance in first-degree relatives who subsequently developed type 2 diabetes.
Insulin resistance and β-cell dysfunction are prerequisites for the development of type 2 diabetes. The relative role of each remains controversial, since studies of at-risk firstdegree relatives of patients with type 2 diabetes have yielded conflicting results. Some studies have demonstrated insulin resistance in first-degree relatives, 9, 12 whereas others have reported that impaired insulin secretion is the first identifiable phenotype. 14 -17 To date, no consensus has been reached.
To gain further insight into the pathogenesis of type 2 diabetes, the present study explored the relationship between a pre-diabetic state and adiponectin. Adiponectin, carotid intima-media thickness (IMT), lipid profiles, insulin resistance and insulin secretion were measured in nonobese first-degree relatives of type 2 diabetes patients at baseline and after 5 years, and compared with results seen in normal subjects without a known family history of diabetes. The subjects were individually matched for age, body mass index (BMI), waist/hip ratio (WHR), blood glucose and fasting lipids in order to differentiate early phenotypic characteristics associated with a hereditary predisposition for type 2 diabetes.
Subjects and methods

SUBJECTS
Between January 2003 and May 2008, nonobese first-degree relatives of type 2 diabetes patients (FDR group) were recruited from the Diabetes Treatment Centre of Shanghai Fifth People's Hospital, Fudan University, Shanghai, China, and subjects without a known family history of diabetes (normal group) were recruited from out-patient physical health clinics. Subjects with abnormal renal, hepatic, heart, lung or thyroid function were excluded from the study. Members of the normal group were individually matched for age, BMI, WHR, blood glucose and fasting lipids with members of the FDR group.
The Human Rights Committee of the Shanghai Fifth People's Hospital of Fudan University approved the study protocol and all participants gave written informed consent.
ASSESSMENT
Biochemical
and anthropometric measurements, together with assessments of endothelial function and atherosclerosis, were made at baseline and after a 5-year follow-up period.
Biochemical measurements
Biochemical measurements included fasting plasma glucose (FPG), 2-h post-load plasma glucose, triglycerides, high-density lipoprotein (HDL)-cholesterol, low-density lipoprotein (LDL)-cholesterol, adiponectin, βcell function and insulin resistance.
Blood samples were drawn from the antecubital vein after overnight fasting for at least 8 h. A 75-g oral glucose tolerance test (OGTT) was then administered, and a second blood sample for glucose was drawn after 120 J Liu, F Wang, Y Cha et al. Adiponectin levels in type 2 diabetes min. Blood samples were stored at -80°C until analysed. Individuals were excluded from the study if they had physician-diagnosed diabetes and were currently receiving medication for diabetes or if they had a FPG level ≥ 6.1 mmol/l or a 2-h post-load glucose level ≥ 7.8 mmol/l at baseline.
Plasma glucose was measured by the glucose oxidase method using a Hitachi 7170S analyser (Hitachi High-Technologies Corp., Tokyo, Japan). The fasting insulin concentration was determined by immunochemiluminescent assay (Roche Diagnostics, Mannheim, Germany). Adiponectin was measured using a commercially available enzyme-linked immunosorbent assay kit (B-Bridge International, Mountain View, CA, USA). Both the intra-and interassay coefficients of variation were < 5.0%.
Lipid profiles (triglycerides, total cholesterol, LDL-cholesterol and HDLcholesterol) were determined using standard laboratory methods. Homeostasis model assessment (HOMA) was utilized to quantify β-cell function (HOMA-β) and insulin resistance (HOMA-IR) using the equations HOMA-β = (20 × insulin)/(glucose -3.5) and HOMA-IR = (glucose × insulin)/22.5.
Anthropometric measurements
Height and weight were measured to the nearest 0.5 cm and 0.1 kg, respectively, and BMI was calculated as weight (kg)/height (m) 2 . Waist and hip circumferences were determined using the mean of two measurements; waist circumference was measured at the smallest circumference of the waist and hip circumference was measured at the widest level of the buttocks. The WHR was then calculated. Body fat percentage was calculated from the BMI, age and sex using a Caucasian prediction formula. 18 
Carotid IMT
Carotid
IMT was measured using ultrasonography in the supine position. Well-trained ultrasonographers, blinded to the subjects' characteristics, produced highresolution B-mode ultrasound images with a 10 MHz linear array transducer (LOGIQ9; General Electric, Milwaukee, WI, USA). Longitudinal scanning was performed from the common carotid artery (CCA) to the bulbus. The IMT was measured on the Bmode scan using electronic calipers to 10 mm proximal to the CCA-bulbus junction. The mean IMT over six segments of both carotid arteries was calculated. The coefficient of variation for measurement of IMT was 3.3 ± 1.60%.
Brachial artery vascular reactivity
Endothelial-dependent vasodilation (EDVD) of the right brachial artery was measured after carotid ultrasound according to the guidelines of the International Brachial Artery Reactivity Task Force. 19 The lumen diameter of the artery was defined as the distance between the leading edge of the near wall-lumen interface echo to the leading edge of the far wall-lumen interface echo. All scans were electrocardiogram triggered and made coincident with the R wave (end of diastole). EDVD was elicited by induced hyperaemia following inflation of a pneumatic tourniquet placed around the forearm, distal to the scanned part of the artery, up to a pressure of 250 mmHg for 5 min followed by sudden deflation. This manoeuvre is recognized to cause shear stress on the endothelial cells which, in turn, releases nitric oxide, producing vasodilation, and is, therefore, a test for endothelial function. Images of the brachial artery were recorded at 10, 30, 60, 90 and 120 s after deflation. The diameter of the brachial artery was determined as the mean of three Adiponectin levels in type 2 diabetes measurements. EDVD was expressed as the percentage increase in the maximal diameter after cuff deflation within 120 s compared to the baseline diameter.
STATISTICAL ANALYSIS
Data were reported as the mean ± SD or the median and 25th and 75th percentiles. All analyses were performed using the SPSS ® statistical package, version 10.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . Differences between the FDR group and the normal group were compared using Student's t-test or the χ 2 -test, as appropriate. Within-group comparisons of baseline and follow-up data were made using a paired t-test. Values of HOMA-IR, HOMA-β and triglycerides were logarithmically transformed due to skewed distributions. Spearman correlation was used to analyse associations between adiponectin and other variables. Multiple linear regression was used to identify independent determinants for adiponectin. A P-value of ≤ 0.05 was considered to be statistically significant.
Results
A total of 53 FDR subjects and 37 normal subjects were included in the study. Of these, 29 FDR subjects and 20 normal subjects were followed up 5 years later. The baseline and follow-up clinical and biological characteristics of the study participants are given in Tables 1 and 2. There were no statistically significant differences between the FDR and normal groups in terms of sex distribution. All participants had normal glucose tolerance, but the 2-h post-load glucose level during the OGTT was significantly higher in the FDR group than in the normal group at baseline (P < 0.05; Table 1 ). Both groups had similar anthropometric measures of adiposity and similar levels of FPG, lipids, carotid IMT and EDVD at baseline (Table 1) . Comparisons between the groups showed that HOMA-IR and HOMA-β levels were significantly higher in the FDR group, and the FDR group also had significantly lower adiponectin levels (P < 0.05 for all comparisons). The lower adiponectin levels in the FDR group remained when adjusting for the small differences in HDLcholesterol (data not shown).
As shown in Table 2 , the WHR increased significantly over the 5-year follow-up period in both the FDR (P < 0.001) and the normal group (P < 0.05), without a change in BMI in either group. In parallel with this increase in central adiposity, the body fat percentage, total cholesterol and triglycerides also significantly increased in both groups (P < 0.05 for all comparisons except total cholesterol in the FDR group which was P < 0.001; Table 2 ). Systolic and diastolic blood pressure levels and EDVD did not change significantly in either group during follow-up ( Table 2) . HOMA-IR did not change significantly over time in the FDR group, whereas β-cell function, as determined by the HOMA-β value, decreased by 39.5% over the same period (P < 0.05). The adiponectin level in the FDR group was 24.3% lower at the 5-year assessment compared with baseline (P < 0.001). The FPG increased significantly in the FDR group at 5 years (P < 0.001; Table 2 ), without a change in post-load glucose. Meanwhile, IMT increased by 5.1% over the same period in the FDR group (P < 0.05) ( Table 2 ). One patient in the FDR group had progressed to diabetes during the 5-year follow-up period. In the normal group, adiponectin decreased by 35.7% over the 5year follow-up period (P < 0.001) ( Table 2 ). Insulin resistance, as measured as HOMA-IR, was 72.2% higher at the 5-year assessment in the normal group (P < 0.05). In line with the increase in insulin resistance, HOMA-β also increased significantly during the same time in the normal group (P < 0.05).
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No correlation was found between the change in adiponectin over time and the evolution of insulin resistance, β-cell function and IMT (data not shown). The change in adiponectin was, however, inversely correlated with the change in HDLcholesterol in the FDR group.
At follow-up, there were significant negative correlations between adiponectin and WHR, FPG, IMT (all P < 0.05) and HOMA-IR (P < 0.01) in the FDR group (Table  3 ). In the normal group, there were significant positive correlations between adiponectin and HDL-and LDL-cholesterol (P < 0.01), and significant negative correlations between adiponectin and FPG (P < 0.05) and HOMA-IR (P < 0.01) ( Table 3) .
Stepwise multiple regression analyses were performed on the results from the FDR group, with adiponectin as a dependent variable and age, WHR, BMI, LDLcholesterol, HDL-cholesterol, FPG, 2 h postload glucose, IMT, EDVD, HOMA-IR and HOMA-β as independent variables. Age, HDL-cholesterol and IMT were shown to be explanatory variables of adiponectin ( 
TABLE 2: Demographic, clinical and biochemical characteristics of non-obese first-degree relatives of type 2 diabetes patients (FDR group) and subjects without a known family history of diabetes (normal group) for whom both baseline and 5-year follow-up
data were available Adiponectin levels in type 2 diabetes analysis revealed that LDL-cholesterol and IMT explained 25% of the variability in the adiponectin level; again, however, the correlation between adioponectin and IMT was not statistically significant.
Discussion
A decrease in adiponectin levels was seen both in the FDR and normal groups over 5 years, and adiponectin levels were shown to correlate negatively with carotid IMT at follow up, although this did not reach statistical significance in this population. A current concept is that decreased adiponectin levels are a key predictor of impaired glucose regulation and type 2 diabetes mellitus. 10 Declining fasting adiponectin levels in relatives have been reported by some, 9, 11 but not all, 12, 13 investigators. The FDR group in the present study demonstrated a lower adiponectin level at baseline compared with the normal group; although blood pressure, WHR and BMI were all similar between the two groups. These data were consistent with previous studies. 9, 11, 12 The reduced level of adipose tissue adiponectin mRNA found in firstdegree relatives 12 suggests that altered adiponectin gene expression plays a pathogenic role in the development of diabetes. Another explanation of the role of adiponectin production and secretion in the FDR group is given in the genetic studies performed by Stumvoll et al., 20 In the present 5-year prospective study, adiponectin levels fell in both groups during follow-up (by 24.3% in the FDR group and by 35.7% in the normal group). The reason for this is unclear, but it may be a consequence of the increased age of the subjects, reflecting a global epidemic. There was a correlation between adiponectin and age, HDLcholesterol and carotid IMT in the FDR group, although for IMT this was not statistically significant (P = 0.059). LDLcholesterol and IMT were also associated with adiponectin levels in normal subjects, although again for IMT this was not statistically significant (P = 0.052). Taken together, these findings could implicate adiponectin in the risk of progression to atherosclerosis in populations with prediabetes and non-diabetes. Accordingly, it has been found that the increased IMT in a cohort of middle-aged diabetes patients could be explained by the decreasing adiponectin level. 21 It is not surprising that, in the present study, hypoadiponectinaemia seemed to be a significant risk factor for later development of atherosclerosis, in agreement with previous studies. 21, 22 There were certain advantages to the present study, including the long 5-year follow-up period, the use of a matched normal control group and the fact that carotid IMT and EDVD can be measured non-invasively 
TABLE 4: Multiple linear regression analyses of plasma adiponectin with various parameters as independent variables a in non-obese first-degree relatives of type 2 diabetes patients (FDR group) and in subjects without a known family history of diabetes (normal group) after 5 years of follow-up Adiponectin levels in type 2 diabetes
and are widely used diagnostic tools both in clinical practice and in epidemiological studies. The results correlated well with the presence of coronary heart disease and future development of myocardial infarction, and are reproducible. 23, 24 The present study was, however, somewhat limited by the small sample size. First-degree relatives of patients with type 2 diabetes are known to be at increased risk of developing diabetes. 25 It is a much debated question as to whether impaired βcell function is an early change or whether it is secondary to insulin resistance in firstdegree relatives. 12, 13 Lihn et al. 12 and Pellmé et al. 9 reported that first-degree relatives with normal glucose tolerance had low insulin sensitivity, whereas there was no difference in insulin secretion. In contrast, Pimenta et al. 14 
and van
Haeften et al. 15 reported that βcell dysfunction was the major determinant of the progression of diabetes in first-degree relatives. Few longitudinal studies in these high-risk groups have been performed, however. Two follow-up studies have assessed insulin resistance and β-cell function in first-degree relatives using different designs. 16, 17 The most recent 7-year follow-up study showed loss of β-cell function, and a strong relationship between the decline in glucose tolerance and β-cell dysfunction in the first-degree relative group. 16 Osei et al. 17 showed that first-degree relatives of African-American patients with type 2 diabetes, who progressed to either impaired glucose tolerance or type 2 diabetes, had 30% lower β-cell function. In general, most studies have suggested that a decline in β-cell function is a critical determinant of deteriorating glucose tolerance in first-degree relatives. In the present study, the first-degree relatives were characterized by increased insulin resistance at baseline. These non-obese relatives had decreased insulin secretion over 5 years, whereas insulin resistance did not change. This finding is similar to that of the prospective study by Cnop et al., 16 which showed that the development of reduced glucose tolerance is possibly associated with β-cell dysfunction in non-obese first-degree relatives. The mechanisms underlying the progressive decline in β-cell function in these individuals are not fully understood. It may be related to a genetic predisposition compounded by environmental exposure.
Adiponectin has previously been reported to be associated with insulin resistance in both epidemiological 2, 26 and experimental 27 studies. The major findings in these studies were that plasma adiponectin was negatively correlated with BMI and WHR, 2, 4, 26 and positively correlated with insulin sensitivity. 2, 4 However, the only finding from the FDR group in the present study was that plasma adiponectin was positively correlated with HDL-cholesterol after adjusting for relevant risk factors. This may be related to the relatively normal range of BMI (18.1 -29.9 kg/m 2 ) that the participants had at the beginning of the study and also the relatively small number of study participants.
In conclusion, in the present study, adiponectin levels were shown to be significantly reduced in non-obese firstdegree relatives of patients with type 2 diabetes and in normal individuals over a 5year period. This study supports previous findings that hypoadiponectinaemia is a risk factor for atherosclerosis. Furthermore, a decrease in β-cell function was also seen in non-obese first-degree relatives at the 5-year follow-up.
